PSI Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
CCMG
PSI Advisors's XPH Position: Q2 2022 in Review
PSI Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2022, closing a stake of 150 shares — an estimated $7K sold.
PSI Advisors first reported a position in XPH in Q3 2021 and held it in 3 quarters. The position peaked at $7K in Q1 2022. 71 funds tracked by Wall St. Rank hold XPH as of Q2 2022.
- PSI Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2022 after selling out during the quarter.
- PSI Advisors sold 150 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2022, an estimated $7K.
- PSI Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2021 and held it in 3 quarters.
- PSI Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $7K in Q1 2022.
- 71 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2022.
Based on PSI Advisors's 13F filing for Q2 2022, filed 18 Jul 2022.